1. Bundesanstalt für Arbeit (1994) Strukturanalyse 1993. Nürnberg
2. Clarke AE, Levinton C, Joseph L et al. (1999) Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis. J Rheumatol 26: 1068–1075
3. Fuchs HA (1993) The use of the Disease Activity Score in the analysis of clinical trials in rheumatoid arthritis. J Rheumatol 20: 1863–1866
4. Guillemin F, Durieux S, Daures JP et al. (2004) Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists. J Rheumatol 31: 1297–1304
5. Hannoveraner Konsensus Gruppe (1999) Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation – Revidierte Fassung des Hannoveraner Konsens. Gesundheitsoekonomie und Qualitaetsmanagement 4: A62–A65